HoxBlinc loss mainly affected chromatin accessibility in promoter proximal regions (68.11%) (Figure 4A), suggesting that HoxBlinc acts as transcription regulator in NUP98-PHF23–driven leukemia. The gene discussed is PHF23; the disease is leukemia.